Latest California Healthline Stories
As Covid Slogs On, Seniors Find Fortitude Waning and Malaise Growing
The spread of the omicron variant has dashed the hopes of many older adults that the country was exiting the worst of the pandemic, leaving them anxious while their patience wears thin.
Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug
An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.
KHN’s ‘What the Health?’: FDA Takes Center Stage
Congress is set to start its once-every-five-years review of the law that authorizes user fees to finance the hiring of personnel to speed the FDA review of drugs. The periodic renewals of “PDUFA” also give lawmakers a chance to make other changes to the agency at the hub of the pandemic. Meanwhile, the FDA could also find itself at the center of the abortion debate and a controversial new medication to treat Alzheimer’s disease. Anna Edney of Bloomberg News, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more.
Pandemic-Fueled Shortages of Home Health Workers Strand Patients Without Necessary Care
Home health and hospice agencies are experiencing extreme worker shortages, which means they can’t provide services to all the patients seeking care.
In California Nursing Homes, Omicron Is Bad, but So Is the Isolation
Omicron infections are surging in residential care facilities, causing massive sickouts among staff members and an uptick in hospitalizations and deaths. The latest visitor restrictions and testing requirements are also compounding the isolation that residents have suffered for almost two years.
Medicare Patients Win the Right to Appeal Gap in Nursing Home Coverage
If federal officials accept a court’s decision, some patients will get a chance to seek refunds for their nursing home and other expenses.
Readers and Tweeters: Give Nurse Practitioners Their Due
KHN gives readers a chance to comment on a recent batch of stories.
¿Por qué Medicare no paga por las pruebas caseras para covid?
Las mismas leyes del programa para los adultos mayores previenen que puedan comprar medicamentos de venta libre y obtener este tipo de pruebas sin una orden médica.
Why Medicare Doesn’t Pay for Rapid At-Home Covid Tests
The laws governing Medicare don’t provide coverage for self-administered diagnostic tests, which is precisely what the rapid antigen tests are and why they are an important tool for containing the pandemic.
Muchos familiares dicen que no pueden conseguir las pruebas ante la enorme demanda y la escasez de suministros, lo que les impide ver a sus seres queridos.